Terms: = Prostate cancer AND CREB1, ENSG00000118260, 1385
37 results:
1. scTIGER: A Deep-Learning Method for Inferring Gene Regulatory Networks from Case versus Control scRNA-seq Datasets.
Dautle M; Zhang S; Chen Y
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686146
[TBL] [Abstract] [Full Text] [Related]
2. ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer.
Nie J; Zhang P; Liang C; Yu Y; Wang X
Free Radic Biol Med; 2023 Aug; 205():318-331. PubMed ID: 37355053
[TBL] [Abstract] [Full Text] [Related]
3. Resistance Exercise Counteracts the Impact of Androgen Deprivation Therapy on Muscle Characteristics in cancer Patients.
Overkamp M; Houben LHP; Aussieker T; van Kranenburg JMX; Pinckaers PJM; Mikkelsen UR; Beelen M; Beijer S; van Loon LJC; Snijders T
J Clin Endocrinol Metab; 2023 Sep; 108(10):e907-e915. PubMed ID: 37161470
[TBL] [Abstract] [Full Text] [Related]
4. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.
Scovell JM; Stovsky M; Partin A; Lotan Y; Baniel J; Dineen M; Hafron J; Manickam K; Pliskin M; Wagner M; Kestranek A; Klein EA
Urology; 2023 May; 175():132-136. PubMed ID: 36804443
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Spectrum of Secondary Solid Tumors of the prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases.
Acosta AM; Gordetsky JB; Collins K; Osunkoya AO; Sangoi AR; Miyamoto H; Kao CS; Trpkov K; Van Leenders GJLH; Wobker SE; Maclean F; Lal P; Daniel RE; Brimo F; Wasco M; Hirsch MS; Baniak N; Diaz-Perez JA; Cornejo KM; Choy B; Mehra R; Williamson SR; Epstein JI; Matoso A
Am J Surg Pathol; 2022 Sep; 46(9):1269-1276. PubMed ID: 35900850
[TBL] [Abstract] [Full Text] [Related]
6. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
[TBL] [Abstract] [Full Text] [Related]
7. Study of transcription factor druggabilty for prostate cancer using structure information, gene regulatory networks and protein moonlighting.
Dey A; Sen S; Maulik U
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34849560
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant creb1 activation in prostate cancer disrupts normal prostate luminal cell differentiation.
Watson MJ; Berger PL; Banerjee K; Frank SB; Tang L; Ganguly SS; Hostetter G; Winn M; Miranti CK
Oncogene; 2021 May; 40(18):3260-3272. PubMed ID: 33846571
[TBL] [Abstract] [Full Text] [Related]
9. Abiraterone Acetate Induces creb1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in prostate cancer Cells.
Pan W; Zhang Z; Kimball H; Qu F; Berlind K; Stopsack KH; Lee GM; Choueiri TK; Kantoff PW
Clin Cancer Res; 2021 Apr; 27(7):2087-2099. PubMed ID: 33495313
[TBL] [Abstract] [Full Text] [Related]
10. Ablation of LGR4 signaling enhances radiation sensitivity of prostate cancer cells.
Liang F; Zhang H; Cheng D; Gao H; Wang J; Yue J; Zhang N; Wang J; Wang Z; Zhao B
Life Sci; 2021 Jan; 265():118737. PubMed ID: 33171177
[TBL] [Abstract] [Full Text] [Related]
11. Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis.
Hu SL; Wang D; Yuan FL; Lei QF; Zhang Y; Cheng JZ
Medicine (Baltimore); 2020 Jul; 99(30):e21372. PubMed ID: 32791747
[TBL] [Abstract] [Full Text] [Related]
12. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study.
Kakkos SK; Arnaoutoglou E; Tsolakis IA; Giannoukas A; Papadimitriou CA; Kentepozidis N; Boukovinas I; Kalofonos HP; Labropoulos N; Matsagkas M
Int Angiol; 2020 Apr; 39(2):112-117. PubMed ID: 32057213
[TBL] [Abstract] [Full Text] [Related]
13. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
14. E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.
Jolly MK; Ware KE; Xu S; Gilja S; Shetler S; Yang Y; Wang X; Austin RG; Runyambo D; Hish AJ; Bartholf DeWitt S; George JT; Kreulen RT; Boss MK; Lazarides AL; Kerr DL; Gerber DG; Sivaraj D; Armstrong AJ; Dewhirst MW; Eward WC; Levine H; Somarelli JA
Mol Cancer Res; 2019 Jun; 17(6):1391-1402. PubMed ID: 30862685
[TBL] [Abstract] [Full Text] [Related]
15. c-Jun Contributes to Transcriptional Control of GNA12 Expression in prostate cancer Cells.
Udayappan UK; Casey PJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299
[No Abstract] [Full Text] [Related]
16. Integrative analysis identifies targetable creb1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
[TBL] [Abstract] [Full Text] [Related]
17. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Goodson WH; Lowe L; Carpenter DO; Gilbertson M; Manaf Ali A; Lopez de Cerain Salsamendi A; Lasfar A; Carnero A; Azqueta A; Amedei A; Charles AK; Collins AR; Ward A; Salzberg AC; Colacci A; Olsen AK; Berg A; Barclay BJ; Zhou BP; Blanco-Aparicio C; Baglole CJ; Dong C; Mondello C; Hsu CW; Naus CC; Yedjou C; Curran CS; Laird DW; Koch DC; Carlin DJ; Felsher DW; Roy D; Brown DG; Ratovitski E; Ryan EP; Corsini E; Rojas E; Moon EY; Laconi E; Marongiu F; Al-Mulla F; Chiaradonna F; Darroudi F; Martin FL; Van Schooten FJ; Goldberg GS; Wagemaker G; Nangami GN; Calaf GM; Williams G; Wolf GT; Koppen G; Brunborg G; Lyerly HK; Krishnan H; Ab Hamid H; Yasaei H; Sone H; Kondoh H; Salem HK; Hsu HY; Park HH; Koturbash I; Miousse IR; Scovassi AI; Klaunig JE; Vondráček J; Raju J; Roman J; Wise JP; Whitfield JR; Woodrick J; Christopher JA; Ochieng J; Martinez-Leal JF; Weisz J; Kravchenko J; Sun J; Prudhomme KR; Narayanan KB; Cohen-Solal KA; Moorwood K; Gonzalez L; Soucek L; Jian L; D'Abronzo LS; Lin LT; Li L; Gulliver L; McCawley LJ; Memeo L; Vermeulen L; Leyns L; Zhang L; Valverde M; Khatami M; Romano MF; Chapellier M; Williams MA; Wade M; Manjili MH; Lleonart ME; Xia M; Gonzalez MJ; Karamouzis MV; Kirsch-Volders M; Vaccari M; Kuemmerle NB; Singh N; Cruickshanks N; Kleinstreuer N; van Larebeke N; Ahmed N; Ogunkua O; Krishnakumar PK; Vadgama P; Marignani PA; Ghosh PM; Ostrosky-Wegman P; Thompson PA; Dent P; Heneberg P; Darbre P; Sing Leung P; Nangia-Makker P; Cheng QS; Robey RB; Al-Temaimi R; Roy R; Andrade-Vieira R; Sinha RK; Mehta R; Vento R; Di Fiore R; Ponce-Cusi R; Dornetshuber-Fleiss R; Nahta R; Castellino RC; Palorini R; Abd Hamid R; Langie SA; Eltom SE; Brooks SA; Ryeom S; Wise SS; Bay SN; Harris SA; Papagerakis S; Romano S; Pavanello S; Eriksson S; Forte S; Casey SC; Luanpitpong S; Lee TJ; Otsuki T; Chen T; Massfelder T; Sanderson T; Guarnieri T; Hultman T; Dormoy V; Odero-Marah V; Sabbisetti V; Maguer-Satta V; Rathmell WK; Engström W; Decker WK; Bisson WH; Rojanasakul Y; Luqmani Y; Chen Z; Hu Z
Carcinogenesis; 2015 Jun; 36 Suppl 1(Suppl 1):S254-96. PubMed ID: 26106142
[TBL] [Abstract] [Full Text] [Related]
18. Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.
Bon H; Wadhwa K; Schreiner A; Osborne M; Carroll T; Ramos-Montoya A; Ross-Adams H; Visser M; Hoffmann R; Ahmed AA; Neal DE; Mills IG
Mol Cancer Res; 2015 Apr; 13(4):620-635. PubMed ID: 25548099
[TBL] [Abstract] [Full Text] [Related]
19. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract] [Full Text] [Related]
20. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.
Li X; Zhang B; Wu Q; Ci X; Zhao R; Zhang Z; Xia S; Su D; Chen J; Ma G; Fu L; Dong JT
Int J Cancer; 2015 Feb; 136(3):536-46. PubMed ID: 24931571
[TBL] [Abstract] [Full Text] [Related]
[Next]
